Navigation Links
Doubling Tamiflu Dose for Severe Flu Doesn't Help: Study
Date:5/31/2013

THURSDAY, May 30 (HealthDay News) -- People with a severe case of the flu don't benefit from taking double doses of the antiviral drug Tamiflu, according to a new study conducted in Southeast Asia.

Tamiflu (oseltamivir) stocks could be conserved during pandemics if doctors prescribe only standard doses of this medication, World Health Organization experts suggested.

The study involved 326 patients diagnosed with severe flu at 13 hospitals in Indonesia, Singapore, Thailand and Vietnam between April 2007 and February 2010. Most of the patients were children younger than 15, but some adults also were included.

Health-care workers treated the patients with either a standard dose of Tamiflu (75 milligrams twice daily or the children's equivalent), or a double dose of the medication (150 milligrams twice daily or children's equivalent) over the course of five days.

Patients' virus levels were measured through nose and throat swabs. Researchers then tracked how many patients died, were admitted to the intensive care unit or required the help of a ventilator to breath.

After five days of treatment, there were no differences between the patients on a standard dose of Tamiflu and those given the double dose. Moreover, no differences were seen in death rates or other adverse events, the study found.

The findings were published online May 30 in the journal BMJ.

The study authors concluded that there's no added benefit from a higher dose of Tamiflu to treat severe flu, according to a journal news release.

In an accompanying editorial, Ian Barr and Aeron Hurt from the WHO Collaborating Centre for Reference and Research on Influenza, wrote that a double dose of Tamiflu "is unlikely to significantly improve the clinical outcomes of severe cases of seasonal influenza."

They added that the study's findings "could help to preserve oseltamivir (Tamiflu) stocks during a future pandemic if clinici
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Doubling Up on Cold, Flu Remedies May Harm Liver
2. Doubling down against diabetes
3. Doubling down on heart failure: Researchers discover new route to disease, and drugs to match
4. New China Bird Flu May Be Resistant to Tamiflu
5. Spot Shortages of Flu Vaccine, Tamiflu Reported, FDA Head Says
6. Flu Drug Tamiflu OK for Babies Under 1: FDA
7. Release all Tamiflu data as promised, argue researchers
8. Vaginal Mesh Lawsuit Filed by Wright & Schulte LLC on Behalf of Iowa Woman Who Sustained Severe, Permanent Injuries Allegedly Due to Defective Ethicon Bladder Mesh
9. Telcom & Data Introduces Wheelock SAFEPATH® SP40S Emergency Evacuation System, An Effective Office Tool to Protect Employees from Severe Weather Threats
10. Ten Skechers Lawsuits Filed by Wright & Schulte on Behalf of Consumers Who Sustained Severe Tendon Damage Allegedly Due to Wearing Skechers Shape-Ups
11. New Treatment for Severe Asthma Introduced at St. Elizabeth Health Center
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Doubling Tamiflu Dose for Severe Flu Doesn't Help: Study
(Date:3/29/2015)... North American Seminars receives Texas Board Physical ... Courses . , Utilizing Pilates to Enhance ... approval # 56399TX      , The Interactive Shoulder ... - 10.5 hours - Texas Board of Physical Therapy ... of the SI Joint - 10 hours - Texas ...
(Date:3/28/2015)... Tucson, AZ. (PRWEB) March 28, 2015 ... according to a new study by researchers ... (HSPH). , Produced with the support of the Coffee ... the journal Molecular Psychiatry this past fall, the study—one ... a meta-analysis of genomic data from more than 120,000 ...
(Date:3/28/2015)... York, New York (PRWEB) March 28, 2015 ... http://www.vaginalmeshlawsuit2015.com/ ) involving devices manufactured by C.R. Bard, ... litigation underway in U.S. District Court, Southern District ... S. Grand, is serving on the Plaintiffs’ Steering ... 24th, the Court has granted certain defendants named ...
(Date:3/28/2015)... 2015 An article in Fortune on ... prove critical to organizations that deal with PCI (Payment ... of data security, is worsening . Using numbers ... every major category out of the twelve measured improved, ... all the craziness that has gone on in the ...
(Date:3/28/2015)... Vegas, NV (PRWEB) March 28, 2015 ... injuries is a growing field in orthopaedic medicine. While ... labral tear to confirm the pain etiology, research presented ... ( AOSSM ) Specialty Day suggests that pain relief ... following arthroscopic hip surgery. , “Our study looked ...
Breaking Medicine News(10 mins):Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 2Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 3Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 3Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 4Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2
... Streamline Health Solutions, Inc. (Nasdaq: STRM ) today announced the financial ... , , Highlights of the quarter and the nine-month ... Revenues increased 11% versus comparable quarter in the previous year; , ... , Year-to-date company has won 8 total new ...
... role in immune, inflammatory processes, study says , , ... have higher levels of the obesity-related hormone leptin than ... study included 77 psoriasis patients and a control group ... researchers gathered health information about the participants and analyzed ...
... Dec. 15 Following is a statement from Michael ... in regards to its financial exposure with Madoff Securities: ... Health System,s financial exposure with Madoff Securities is limited to ... who stipulated that the funds be invested with Madoff. The ...
... footwear choices, properly moisturizing can soothe holiday soles. , ... Bethesda, MD ... an extra boost of holiday cheer, the same winter weather that puts ... fierce toll on their feet. , , , , ,“Foot ailments ...
... for delivering,albuterol, a fast-acting bronchial dilator, currently use propellants ... beginning December 31st,2009, or replacement HFA,s. Both propellants are ... at near-supersonic speeds. , ... stream of air by ejecting,the medication from a microfluidic ...
... of all Californians under age 65 were without health insurance ... brief released today by the UCLA Center for Health Policy ... data from the California Health Interview Survey (CHIS), the policy ... insurance coverage for all or some of 2007, the most ...
Cached Medicine News:Health News:Streamline Health Solutions, Inc. Reports Third Quarter Results 2Health News:Streamline Health Solutions, Inc. Reports Third Quarter Results 3Health News:Streamline Health Solutions, Inc. Reports Third Quarter Results 4Health News:Streamline Health Solutions, Inc. Reports Third Quarter Results 5Health News:Streamline Health Solutions, Inc. Reports Third Quarter Results 6Health News:Streamline Health Solutions, Inc. Reports Third Quarter Results 7Health News:Streamline Health Solutions, Inc. Reports Third Quarter Results 8Health News:Streamline Health Solutions, Inc. Reports Third Quarter Results 9Health News:Streamline Health Solutions, Inc. Reports Third Quarter Results 10Health News:Streamline Health Solutions, Inc. Reports Third Quarter Results 11Health News:Obesity-Related Hormone Tied to Psoriasis 2Health News:North Shore-LIJ Health System Exposure With Madoff Securities Limited to $5.7M 2Health News:‘Tis The Season to Avoid Foot Follies: Tips to Keep You on Your Feet 2Health News:Next Safety Develops an Air-Based Asthma Medication Inhaler That Does Not Use a Refrigerant Propellant 2Health News:Next Safety Develops an Air-Based Asthma Medication Inhaler That Does Not Use a Refrigerant Propellant 3Health News:Nearly 6.4 million Californians lack health insurance, report shows 2
(Date:3/27/2015)... , March 27, 2015   Hospira, ... leader in biosimilars and the world,s leading provider ... studies that support an evaluation of biosimilarity of ... Food and Drug Administration (FDA) conditionally approved name ... EPOGEN™ (epoetin alfa). These study data were presented ...
(Date:3/27/2015)... , March 27, 2015  Delcath Systems, ... and medical device company focused on oncology with ... metastatic liver cancers, announces the reporting of data ... Melphalan Hydrochloride for Injection with the Delcath Hepatic ... poster presentation at the Society of Surgical Oncology ...
(Date:3/26/2015)... WOODBRIDGE, ON , March 26, 2015 /PRNewswire/ - Pivotal ... specialty pharmaceutical company with a focus on Omega-3 therapies ... March 25, 2015 it issued 763,752 common shares of ... payment of interest for the period of December 5 ... on its outstanding Convertible Notes that is due on ...
Breaking Medicine Technology:Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 2Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 4Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 5Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2
... 16, 2011 DecisionView Inc., a leading provider ... for life sciences companies, today announced that a ... Roche have agreed to participate in the creation ... based on real-world clinical performance data. Each of ...
... N.J., June 16, 2011 Ferring Pharmaceuticals Inc. proudly ... Houston in an effort to help increase awareness about ... of healthy aging. The NSG is ... and is organized by the National Senior Games Association, ...
Cached Medicine Technology:DecisionView to Create Clinical Trial Enrollment Benchmarks 2DecisionView to Create Clinical Trial Enrollment Benchmarks 3Ferring Pharmaceuticals Inc. Congratulates All 2011 Summer National Senior Games Athletes 2Ferring Pharmaceuticals Inc. Congratulates All 2011 Summer National Senior Games Athletes 3Ferring Pharmaceuticals Inc. Congratulates All 2011 Summer National Senior Games Athletes 4
... Photosilk Plus offers a new and efficient ... medicine treatments. Springing from ongoing research and ... is not just a light source, but ... Photosilk Plus represents new horizons in pulsed-light-based ...
Auto Refkeratomoeter...
The convenience of safe and precise Patient Controlled Analgesia in a flexible system designed with advanced technology. This is progressive, innovative, and effective pain management in a sophistica...
Pain management can be complicated. But that doesn't mean your PCA infusion system should be. The new SYNDEO PCA Syringe Pump streamlines pain therapy with a powerful combination of intelligent desig...
Medicine Products: